insights_auto
Por qué ha bajado ANW 4,88%?
Profundizarchevron_right
ANW:FRA
Immuron Ltd
0,020 €
arrow_downward
-4,88%(-0,0010) 1 d
9 oct, 22:00:00 GMT+2 · EUR
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de ANW...
Abrir
0,02 €
Alto
0,02 €
Bajo
0,02 €
Cap. burs.
10,10 M
Vol. medio
627,00
Volumen
0,00
Máximo en 52 sem.
0,04 €
Mínimo en 52 sem.
0,01 €
N.º de empleados
8
Abrir
0,02 €
Alto
0,02 €
Bajo
0,02 €
Cap. burs.
10,10 M
Vol. medio
627,00
Volumen
0,00
Máximo en 52 sem.
0,04 €
Mínimo en 52 sem.
0,01 €
N.º de empleados
8
Noticias
De fuentes web y partners de noticias
https://www.dars.gov.et/
·
hace 6 días
Immuron (IMRN) Slips 1.83% to $1.07 as Shares Drift Toward Lower Support - OBV Divergence
Perfil
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Acerca de Immuron Ltd